What is the effect of angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers on patient and graft survival rates after renal transplantation?
The use of angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers has been associated with prolonged patient and graft survival after renal transplantation (Heinze et al., 2006). However, other studies have shown that there is no improvement in patient or graft survival with these medications (Opelz et al., 2006). Therefore, further research is needed to determine the effect of these medications on patient and graft survival rates after renal transplantation.